Introduction 50
Globally, vaccination is recognized as one of the most cost-effective public health measures [1] . 51 It is estimated that a 60% reduction in measles mortality occurred worldwide since 1999, 52 however, measles still remains a leading cause of vaccine-preventable death in children aged 53 less than 5 years in sub-Saharan Africa.
[2] 54 Over the past twenty years, concerns have been raised regarding the spurious link between the 55 measles, mumps, rubella (MMR) vaccines and development of autism and autism spectrum 56 disorders (ASD) [3] . Such concerns contributed to a decrease in vaccine uptake and an increase 57 in the number of cases of many vaccine preventable diseases over the past several years in 58 Europe and the USA [4] [5] [6] . 59 Vaccine hesitancy is one of the contributors to a low vaccination coverage in both developed and 60 developing countries [7] . As defined by the WHO Strategic Advisory Group on Experts (SAGE) 61 on Immunization: "Vaccine hesitancy refers to a delay in acceptance or refusal of vaccination 62 despite availability of vaccination services. Vaccine hesitancy is complex and context-specific, 63 varying across time and place. It is influenced by factors, such as complacency, convenience, and 4 64 confidence" [8] . Complacency exists where perceived risks of vaccine-preventable diseases are 65 low; convenience relates to access issues such as the physical availability, ability to understand 66 (language and health literacy), and vaccine confidence is defined as the level of trust in a vaccine 67 or provider. [6] 68 In Sudan, the Expanded Program on Immunization (EPI) was launched in 1976. The EPI services 69 are provided free of charge through the Primary Health Care centers. Communication strategies 70 that address vaccine hesitancy were adopted as a policy by the federal ministry of health in order 71 to enhance community demand for vaccines [9] .
72
Sudan is still far from eliminating measles, as the measles vaccine coverage should be and 73 sustained at 95% for the first (MCV1) and second (MCV2) doses of the vaccine, however, in 74 2017 the national coverage was 90% and 72% for MCV1 and MCV2 respectively [10] . Another 75 indicator is to reduce the endemic incidence of measles to zero cases per 1 million of population. 76 However, in 2017, an unpublished report from WHO indicated that the incidence of measles was 77 14.2 per 1 million.
78
Little is known about the determinants of the low measles vaccine coverage in Sudan. For a 79 further understanding of measles vaccine hesitancy in Sudan, this study aims to explore the 80 opinions of Expanded Program on Immunization (EPI) officers/experts and front-line vaccine 81 providers who are based in Khartoum state. 
Methods

84
Study design 85 This study had a cross-sectional design and data were collected using semi-structured interviews 86 during the period January -March 2018. The topic list for the interviews was developed and 87 structured using the model framework ''Determinants of Vaccine Hesitancy Matrix'' that was 88 developed by the WHO-SAGE Working Group. It distinguishes between three groups of 89 determinants: contextual influences, such as religion and geographic barriers, individual and group 90 influences, such as beliefs and attitudes about health and prevention, and vaccine or vaccination-91 specific influences, such as the mode of administration and the vaccination schedule. 93 Two groups were included for the individual interviews. Firstly, the Expanded Program on 94 Immunization (EPI) officers/ experts at the federal ministry of health, Khartoum state ministry of 95 health, WHO and UNICEF. The EPI officers/experts were selected for having at least ten years 96 of experience in the field of immunization and having a leading role inside and/or outside 121 The individual interviews with the participants from the two groups were conducted in the 122 Arabic language. The data were recorded, transcribed, coded manually, and then analyzed 
92
Groups and participants selection
Data collection and analysis
Results
133
The interviews were completed with 14 participants, as saturation was reached after 13 134 interviews. Five were EPI officers/experts and nine were front-line vaccine providers. The 135 demographic and professional characteristics of the participants are summarized in Table 1 . '' When the child cries at night due to fever after vaccination, the father tells his wife that she 220 took a healthy child, who is now ill, telling the mother not to take the child again for 
Vaccine-and vaccination-specific factors 243
Mode of administration was identified as a contributing factor in measles vaccine hesitancy by 244 two immunization officers/experts and one front-line providers.
245 246 ''when a mother feels that her child is going strong at the age of 9 months, they think that this 247 child is well and that there is no need to vaccinate him or to expose him to an injection (i.e. ways for reminding parents about the time of the next dose including telling verbally, write on 264 the card, and/ or even using mobile phone call.) as a causal factor in measles vaccine hesitancy. Limitations of the study 330 Firstly, this study was qualitative and Khartoum-based. Furthermore, the selection of vaccine 331 providers was also intentionally biased as it was done purposively in geographical areas where 332 measles vaccination uptake was low or where measles outbreaks were reported to be more 333 frequent and prevalent. Hence, findings cannot be generalized to the whole population of vaccine 334 providers and EPI officers/experts in Sudan. Secondly, most participants mentioned names of 335 some ethnic and religious groups without a clear definition of who exactly these groups are (e.g.
336
"Falatta " and ''Ansar Al-Sunna"). This might complicate the search for the right target group for 337 interventions. We did this study into vaccine hesitancy in circumstances where people have a 338 relatively easy access to vaccination services. We have to acknowledge that there are other areas 339 in Sudan, where there is the perhaps even more fundamental difficulty of people not having 340 access to vaccination services in the first place. 
